Symptom of Autism Versus Confirmed Diagnosis in Cystic Kidney Disease: A Multi- Method Assessment Combining Screening and In-Depth Diagnostics

Background Hereditary cystic kidney diseases (CysKDs) are increasingly recognized as multisystem disorders with neurodevelopmental involvement. Previous studies have reported elevated symptoms of autism spectrum disorder (ASD) in specific CysKDs, but whether these elevations correspond to confirmed ASD diagnoses remains unclear. Method We assessed social-communication difficulties and broader autistic symptom burden in a multicenter cohort of 100 individuals aged 1–24 years with genetically confirmed CysKDs, including Bardet–Biedl syndrome (BBS; n = 37), HNF1B deletions ( n = 24), intragenic HNF1B pathogenetic variants ( n = 7), and other rare CysKDs. All participants underwent standardized questionnaire-based phenotyping; a subsample of 21 additionally received in-depth ASD diagnostics using ADOS-2 and ADI-R. Results Individuals with HNF1B deletions showed greater symptoms of ASD burden than those with intragenic variants, including more pronounced impairments in social responsiveness ( p = .041, d = 1.01) and social communication ( p = .040, d = 0.71). Exploratory analyses further showed greater social-responsiveness difficulties in BBS and HNF1B deletion groups compared with other CysKDs, F (2,87) = 6.44, p = .003. Importantly, elevated screening-based symptom burden did not uniformly correspond to a confirmed ASD diagnosis in the in-depth diagnostic subsample. ADOS-2 severity did not differ significantly between BBS ( n = 11) and HNF1B deletions ( n = 9). Conclusions These findings confirm substantial symptoms of ASD burden in BBS and HNF1B -associated disease but demonstrate that screening elevations should not be equated with ASD diagnosis. Comprehensive diagnostic assessment is therefore warranted following positive screening

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11534298/v1
Primary Topic
Autism Spectrum Disorder Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Symptom of Autism Versus Confirmed Diagnosis in Cystic Kidney Disease: A Multi- Method Assessment Combining Screening and In-Depth Diagnostics

Clara Marie Nittel, Miriam Senger, Katja Becker, Inge Kamp‐Becker et al.
1 links
Research Square
Autism Spectrum Disorder Research
preprint

Symptom of Autism Versus Confirmed Diagnosis in Cystic Kidney Disease: A Multi- Method Assessment Combining Screening and In-Depth Diagnostics

Clara Marie Nittel, Miriam Senger, Katja Becker, Inge Kamp‐Becker, Metin Cetiner, Jens Christian König, Stefanie Weber, Martin Konrad
preprint en

Abstract

Background Hereditary cystic kidney diseases (CysKDs) are increasingly recognized as multisystem disorders with neurodevelopmental involvement. Previous studies have reported elevated symptoms of autism spectrum disorder (ASD) in specific CysKDs, but whether these elevations correspond to confirmed ASD diagnoses remains unclear. Method We assessed social-communication difficulties and broader autistic symptom burden in a multicenter cohort of 100 individuals aged 1–24 years with genetically confirmed CysKDs, including Bardet–Biedl syndrome (BBS; n = 37), HNF1B deletions ( n = 24), intragenic HNF1B pathogenetic variants ( n = 7), and other rare CysKDs. All participants underwent standardized questionnaire-based phenotyping; a subsample of 21 additionally received in-depth ASD diagnostics using ADOS-2 and ADI-R. Results Individuals with HNF1B deletions showed greater symptoms of ASD burden than those with intragenic variants, including more pronounced impairments in social responsiveness ( p = .041, d = 1.01) and social communication ( p = .040, d = 0.71). Exploratory analyses further showed greater social-responsiveness difficulties in BBS and HNF1B deletion groups compared with other CysKDs, F (2,87) = 6.44, p = .003. Importantly, elevated screening-based symptom burden did not uniformly correspond to a confirmed ASD diagnosis in the in-depth diagnostic subsample. ADOS-2 severity did not differ significantly between BBS ( n = 11) and HNF1B deletions ( n = 9). Conclusions These findings confirm substantial symptoms of ASD burden in BBS and HNF1B -associated disease but demonstrate that screening elevations should not be equated with ASD diagnosis. Comprehensive diagnostic assessment is therefore warranted following positive screening

Research Square
Philipps University of Marburg (DE), Universitätsklinikum Gießen und Marburg (DE), University Hospital Münster (DE), Essen University Hospital (DE)
Good health and well-being
Autism Spectrum Disorder Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon